论文部分内容阅读
目的:观察盐酸氨溴索治疗新生儿重症吸入性肺炎的疗效。方法:230例重症吸入性肺炎患儿随机分为治疗组和对照组,两组均常规给予相同的抗感染、保暖及纠正缺氧、酸碱平衡、电解质紊乱等对症治疗,治疗组同时加用盐酸氨溴索7.5 mg+10%葡萄糖注射液10 ml静脉滴注。结果:治疗组经治疗后口唇青紫、呼吸困难、肺部湿啰音明显改善,而且治疗时间比对照组明显缩短,差异有统计学意义(P<0.01)。治疗组痊愈68例,显效32例,好转8例,显效率为89.3%,优于对照组(P<0.05)。结论:盐酸氨溴索治疗新生儿重症吸入性肺炎疗效显著,值得推广。
Objective: To observe the efficacy of ambroxol hydrochloride in the treatment of neonatal severe aspiration pneumonia. Methods: 230 infants with severe aspiration pneumonia were randomly divided into treatment group and control group. The two groups were routinely given the same anti-infective, warm-keeping and correct symptomatic treatment of hypoxia, acid-base balance, electrolyte imbalance. The treatment group Ambroxol hydrochloride 7.5 mg + 10% glucose injection 10 ml intravenous infusion. Results: After treatment, the treatment group had bruising, difficulty breathing and wet rales of the lungs. The treatment time was significantly shorter than that of the control group (P <0.01). The treatment group cured 68 cases, 32 cases markedly improved, 8 cases improved, markedly effective rate was 89.3%, better than the control group (P <0.05). Conclusion: Ambroxol hydrochloride is effective in treating neonatal severe aspiration pneumonia and is worth promoting.